Literature DB >> 29319697

FDA approves hereditary blindness gene therapy.

.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29319697     DOI: 10.1038/nbt0118-6a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  First AAV gene therapy poised for landmark approval.

Authors:  Eric Smalley
Journal:  Nat Biotechnol       Date:  2017-11-09       Impact factor: 54.908

  1 in total
  18 in total

1.  To win at gene therapy, companies pick viruses with production credentials.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2019-01-03       Impact factor: 54.908

2.  Rollout of high-priced cell and gene therapies forces payer rethink.

Authors:  Melanie Senior
Journal:  Nat Biotechnol       Date:  2018-04-05       Impact factor: 54.908

3.  A Common Outer Retinal Change in Retinal Degeneration by Optical Coherence Tomography Can Be Used to Assess Outcomes of Gene Therapy.

Authors:  Myung Kuk Joe; Wenbo Li; Suja Hiriyanna; Wenhan Yu; Shreya A Shah; Mones Abu-Asab; Haohua Qian; Zhijian Wu
Journal:  Hum Gene Ther       Date:  2019-12-04       Impact factor: 5.695

4.  Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina.

Authors:  Patrizia Tornabene; Ivana Trapani; Renato Minopoli; Miriam Centrulo; Mariangela Lupo; Sonia de Simone; Paola Tiberi; Fabio Dell'Aquila; Elena Marrocco; Carolina Iodice; Antonella Iuliano; Carlo Gesualdo; Settimio Rossi; Laura Giaquinto; Silvia Albert; Carel B Hoyng; Elena Polishchuk; Frans P M Cremers; Enrico M Surace; Francesca Simonelli; Maria A De Matteis; Roman Polishchuk; Alberto Auricchio
Journal:  Sci Transl Med       Date:  2019-05-15       Impact factor: 19.319

Review 5.  Development of New Strategies Using Extracellular Vesicles Loaded with Exogenous Nucleic Acid.

Authors:  Nicola Salvatore Orefice
Journal:  Pharmaceutics       Date:  2020-07-26       Impact factor: 6.321

6.  Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer.

Authors:  Julien Baruteau; Dany P Perocheau; Joanna Hanley; Maëlle Lorvellec; Eridan Rocha-Ferreira; Rajvinder Karda; Joanne Ng; Natalie Suff; Juan Antinao Diaz; Ahad A Rahim; Michael P Hughes; Blerida Banushi; Helen Prunty; Mariya Hristova; Deborah A Ridout; Alex Virasami; Simon Heales; Stewen J Howe; Suzanne M K Buckley; Philippa B Mills; Paul Gissen; Simon N Waddington
Journal:  Nat Commun       Date:  2018-08-29       Impact factor: 14.919

7.  Codon-Optimization of Wild-Type Adeno-Associated Virus Capsid Sequences Enhances DNA Family Shuffling while Conserving Functionality.

Authors:  Marti Cabanes-Creus; Samantha L Ginn; Anais K Amaya; Sophia H Y Liao; Adrian Westhaus; Claus V Hallwirth; Patrick Wilmott; Jason Ward; Kimberley L Dilworth; Giorgia Santilli; Arkadiusz Rybicki; Hiroyuki Nakai; Adrian J Thrasher; Adrian C Filip; Ian E Alexander; Leszek Lisowski
Journal:  Mol Ther Methods Clin Dev       Date:  2018-11-01       Impact factor: 6.698

Review 8.  Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy.

Authors:  Dongsheng Duan
Journal:  Mol Ther       Date:  2018-07-17       Impact factor: 11.454

9.  Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors.

Authors:  Johanna Reul; Janina Frisch; Christine E Engeland; Frederic B Thalheimer; Jessica Hartmann; Guy Ungerechts; Christian J Buchholz
Journal:  Front Oncol       Date:  2019-02-14       Impact factor: 6.244

Review 10.  Updates on Gene Therapy for Diabetic Retinopathy.

Authors:  Jiang-Hui Wang; Georgina Eloise Roberts; Guei-Sheung Liu
Journal:  Curr Diab Rep       Date:  2020-05-16       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.